A detailed history of Telemetry Investments, L.L.C. transactions in Paratek Pharmaceuticals, Inc. stock. As of the latest transaction made, Telemetry Investments, L.L.C. holds 483,000 shares of PRTK stock, worth $0. This represents 1.43% of its overall portfolio holdings.

Number of Shares
483,000
Previous 345,000 40.0%
Holding current value
$0
Previous $887,000 1.8%
% of portfolio
1.43%
Previous 1.14%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$1.67 - $2.51 $230,460 - $346,379
138,000 Added 40.0%
483,000 $903,000
Q3 2022

Nov 17, 2022

SELL
$1.96 - $2.93 $294,000 - $439,500
-150,000 Reduced 30.3%
345,000 $887,000
Q2 2022

Aug 15, 2022

BUY
$1.73 - $3.09 $228,360 - $407,880
132,000 Added 36.36%
495,000 $955,000
Q1 2022

May 16, 2022

BUY
$2.94 - $4.77 $296,119 - $480,439
100,721 Added 38.4%
363,000 $1.08 Million
Q4 2021

Feb 14, 2022

BUY
$4.07 - $5.3 $80,443 - $104,754
19,765 Added 8.15%
262,279 $1.18 Million
Q3 2021

Nov 15, 2021

BUY
$4.7 - $7.24 $352,603 - $543,159
75,022 Added 44.79%
242,514 $1.18 Million
Q2 2021

Aug 16, 2021

SELL
$6.81 - $10.93 $25,728 - $41,293
-3,778 Reduced 2.21%
167,492 $1.14 Million
Q1 2021

May 17, 2021

SELL
$6.14 - $8.31 $144,406 - $195,442
-23,519 Reduced 12.07%
171,270 $1.21 Million
Q4 2020

Feb 16, 2021

BUY
$4.58 - $7.14 $180,525 - $281,430
39,416 Added 25.37%
194,789 $1.22 Million
Q3 2020

Nov 16, 2020

BUY
$4.19 - $6.69 $380,757 - $607,940
90,873 Added 140.89%
155,373 $841,000
Q2 2020

Aug 14, 2020

BUY
$2.97 - $5.22 $191,565 - $336,690
64,500 New
64,500 $337,000
Q1 2019

May 15, 2019

SELL
$5.36 - $7.24 $117,920 - $159,280
-22,000 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$4.8 - $11.6 $105,600 - $255,200
22,000 New
22,000 $113,000
Q2 2018

Aug 14, 2018

SELL
$10.2 - $13.9 $417,965 - $569,580
-40,977 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$12.65 - $18.85 $518,359 - $772,416
40,977 New
40,977 $533,000

Others Institutions Holding PRTK

About Paratek Pharmaceuticals, Inc.


  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Telemetry Investments, L.L.C. Portfolio

Follow Telemetry Investments, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Telemetry Investments, L.L.C. with notifications on news.